Can Steroid Injections Cause Skin Discoloration?

Steroid injections can and sometimes do cause skin discoloration, most commonly in the form of lightened patches at or near the injection site. This side effect, known clinically as hypopigmentation, happens because the corticosteroid interferes with how pigment-producing cells in the skin function. The good news is that it usually reverses on its own over several months, but the timeline varies, and the change can be alarming when it appears unexpectedly.

What the Discoloration Actually Looks Like

The most common color change after a steroid injection is hypopigmentation, meaning the skin becomes lighter than the surrounding area. It can show up as a pale or white patch right where the needle went in, but it can also appear as a streak or line extending away from the injection site. That streaking pattern happens when the steroid travels along lymphatic vessels under the skin, causing lightening along the path of those vessels rather than staying confined to one spot.¹ One case report described the effect as “radiated linear depigmentation” surrounding the original injection site, tracing the lymphatic drainage pattern.²

Less commonly, steroid injections can cause hyperpigmentation, where the skin darkens rather than lightens. This is mentioned in the medical literature alongside other soft-tissue side effects like visible tiny blood vessels (telangiectasias) and hair loss at the injection site.³ But lightening is far more frequently reported than darkening, and it is the side effect that catches most patients off guard.

Why Steroids Change Skin Color

The mechanism is surprisingly specific. When a corticosteroid is injected into or near the skin, it does not destroy the melanocytes (the cells responsible for producing pigment). Instead, it suppresses their activity. A recent study examining steroid-induced hypopigmentation at the cellular level found that melanocyte density was actually preserved. The cells were still there in normal numbers, but a key marker of active melanin production was mostly absent or only faintly detectable.⁴ In other words, the pigment factory is still standing, but the machinery inside has been temporarily shut down.

This distinction matters because it separates steroid-induced color change from conditions like vitiligo, where the immune system actually destroys melanocytes. With steroid hypopigmentation, the cells can resume normal function once the drug’s local effect wears off. The corticosteroid also causes blood vessels in the area to constrict, reducing blood flow. One drug used frequently for these injections, triamcinolone, forms tiny crystals at the injection site. Those crystals sitting inside already-constricted blood vessels can reduce oxygen delivery to local tissue, contributing to changes in the skin and underlying fat.⁵

How Long It Takes to Appear and How Long It Lasts

Skin lightening does not happen immediately. In a prospective study tracking patients after extra-articular corticosteroid injections, hypopigmentation developed between four and ten weeks after the injection.⁶ Some case reports describe it appearing even sooner. One patient developed a depigmented patch measuring roughly two by three centimeters just one week after a steroid injection for de Quervain’s tenosynovitis in the wrist.⁷ So the window of onset stretches from about one week to two and a half months, and a patient who looks fine at their two-week follow-up is not necessarily in the clear.

The encouraging part is recovery. In the prospective cohort study, all cases of hypopigmentation eventually resolved completely. The average time to full repigmentation was about seven months, though it ranged from as short as two months to as long as eighteen months.⁶ That is a wide spread, and waiting over a year for your skin to look normal again is understandably frustrating, even when you know it will eventually get better. No active treatment is required in most cases; the melanocytes simply need time to resume pigment production once the steroid’s local concentration drops.

How This Differs from Vitiligo

A white patch on the skin can trigger worry about vitiligo, an autoimmune condition that causes permanent depigmentation. The two look similar on the surface, but they are fundamentally different at the cellular level. In vitiligo, the immune system attacks and destroys melanocytes, leaving skin permanently unable to produce pigment in the affected area. In steroid-induced hypopigmentation, melanocytes are still present and intact; they have just been temporarily suppressed.⁸

The practical takeaway is that if you develop a light patch after a steroid injection, it is almost certainly the injection and not the onset of vitiligo. But the distinction does matter for management. Vitiligo may require phototherapy or immune-modulating treatments and can spread. Steroid-induced lightening stays confined to the injection area and its lymphatic drainage, and it resolves on its own. If there is any doubt, a dermatologist can usually tell the difference based on timing, location, and the history of a recent injection.

Fat Loss and Other Tissue Changes That Come Along

Discoloration rarely shows up in isolation. Corticosteroid injections can also cause subcutaneous fat atrophy, where the fat layer under the skin shrinks, leaving a visible depression or dent. In the same prospective study that tracked skin color changes, about seven percent of patients developed fat atrophy, and all of those cases occurred in women.⁶ One patient who received a steroid injection in the jaw joint area for temporomandibular joint pain developed both a depigmented zone and a visible depression near the injection site within three weeks.⁹ Another patient treated for elbow pain had both noticeable fat loss around the medial epicondyle and a large depigmented area at the injection site.¹⁰

Here is an important difference between the two side effects: while hypopigmentation tends to fully recover, fat atrophy often does not. In the prospective cohort, two out of three fat atrophy cases showed incomplete recovery, a statistically significant difference compared to the color changes, which all resolved.⁶ This means the cosmetic concern that lingers longest after a steroid injection may not be the color change at all, but the dent left behind by lost fat. Corticosteroids also decrease the production of collagen in the skin, contributing to thinning and making the overall tissue changes more pronounced.³

Where on the Body It Happens Most

Steroid-induced skin changes can occur wherever injections are given, but some locations seem more prone than others. The hands and wrists are commonly reported sites, partly because those joints are frequently injected and partly because the skin there is relatively thin. A detailed case study documented steroid-induced hypopigmentation on the back of the hand, with clear cellular-level evidence of melanocyte suppression.⁴ Injections for de Quervain’s tenosynovitis at the wrist, for lateral or medial epicondylitis at the elbow, for Morton’s neuroma in the foot, and for temporomandibular joint pain near the jaw have all produced documented cases of discoloration.

The linear streaking pattern described earlier tends to show up when the injection is placed in or near soft tissue rather than deep in a joint space. One theory is that when the injected volume of corticosteroid exceeds what local binding proteins can absorb, the excess steroid flows into the surrounding tissue and gets picked up by lymphatic vessels, causing a trail of lightened skin along those drainage channels.¹¹ Injections that end up too superficially placed, or in areas where there is less tissue between the needle and the skin surface, carry higher risk for visible skin effects.

Who Is More Vulnerable

People with darker skin are more likely to notice steroid-induced hypopigmentation simply because the contrast between lightened and normal skin is more dramatic. The underlying mechanism appears to happen regardless of skin tone, but the cosmetic impact is far more significant for someone with deeply pigmented skin than for someone with very fair skin, where a light patch might be barely perceptible.

There are also hints that sex plays a role. In the prospective cohort study, unadjusted data suggested that hypopigmentation occurred only in women, though the association weakened after statistical adjustment for other factors. Similarly, all three cases of fat atrophy in that study occurred in women.⁶ The study was small (45 injections), so the numbers should be interpreted cautiously, but the pattern is consistent with other literature noting that women may be more susceptible to soft-tissue side effects from corticosteroid injections.

Children may also be at higher risk, though for a different reason. Pediatric skin is thinner than adult skin, and studies comparing corticosteroid absorption in children versus adults have found that children absorb the drug more readily through their skin, likely because of that thinner barrier.¹² Higher local absorption could translate to a stronger suppressive effect on melanocytes and a greater chance of visible skin changes.

Reducing the Risk

The most straightforward way to minimize discoloration risk is careful injection technique. Placing the needle accurately into the intended deep tissue or joint space, rather than into or near the skin surface, reduces the chance that the corticosteroid will affect melanocytes in the overlying skin. Using ultrasound guidance for joint injections improves accuracy and is increasingly standard practice for exactly this reason.

Injecting a smaller volume, using a less concentrated formulation, and choosing a non-particulate corticosteroid instead of triamcinolone (which forms crystals) are other strategies clinicians use. Since the linear streaking pattern is thought to result from steroid overflow into lymphatic channels, avoiding excessive volume relative to what the tissue can absorb locally is a key prevention strategy.¹¹ Some practitioners also apply gentle pressure to the injection site immediately afterward to help contain the steroid locally, though the evidence for this is largely anecdotal.

One thing worth noting: injections that are too deep can also cause problems. In one case of scar treatment, the clinician concluded that the injection had been placed too deep, allowing steroid crystals to deposit in normal tissue rather than the target scar. The result was linear discoloration and atrophy radiating outward along lymphatic vessels.² So the goal is not just “deep enough” but “accurately placed,” which is a harder target to hit than it sounds.

When Treatment Is Needed

Most steroid-induced hypopigmentation does not require active treatment beyond patience. Since melanocytes are suppressed rather than destroyed, the skin gradually repigments on its own as the drug’s local effect fades. For patients who find the appearance distressing during that waiting period, cosmetic camouflage products can match skin tone and cover the affected area.

For cases where repigmentation is slow or the discoloration is accompanied by fat atrophy, clinicians have tried a few interventions. Serial saline injections into the affected area have been used to help plump up tissue lost to fat atrophy and may help stimulate some recovery.¹⁰ Excimer laser therapy, which delivers targeted ultraviolet light to stimulate melanocyte activity, has also been used in combination with saline injections for stubborn cases. These interventions are not widely standardized, though, and the evidence base consists mostly of case reports and small series rather than controlled trials.

Why Your Doctor Should Mention This Beforehand

Skin discoloration from steroid injections is well-documented in the medical literature, yet many patients report being caught off guard when it happens. This is not just a cosmetic concern; it is a legal one for clinicians. A study reviewing malpractice cases involving corticosteroids found that lack of proper informed consent was alleged in over a third of lawsuits filed.¹³ Negligent use was the most common allegation, appearing in about two-thirds of cases.

If you are about to receive a steroid injection and your clinician has not mentioned the possibility of skin color changes, fat loss, or skin thinning, it is worth asking about these risks directly. The conversation should include what type of corticosteroid is being used, how much is being injected, and what to watch for in the weeks that follow. For people with darker skin tones, where discoloration would be most conspicuous, this discussion is especially relevant.

Steroid Injections Are Not the Only Injectables That Affect Skin Color

It is worth knowing that skin discoloration is not unique to corticosteroids among injectable treatments. Hyaluronic acid dermal fillers, commonly used for cosmetic purposes, carry their own risk of adverse skin effects. A scoping review of complications from facial hyaluronic acid injections found reports of irreversible damage including scarring, skin discoloration, and tissue death, particularly in areas with complex blood vessel anatomy like the upper and mid-face.¹⁴ The mechanisms differ — filler complications typically involve vascular compromise rather than melanocyte suppression — but the lesson is similar. Any time a substance is injected into or near the skin, there is some risk of visible skin changes, and the specific risks depend on the substance, the technique, and the anatomical site.

For patients considering alternatives to corticosteroid injections for pain management or scar treatment, this broader context is useful. Switching away from steroids does not automatically eliminate the risk of skin-level side effects; it changes the nature of the risk. The decision should factor in the specific condition being treated, the alternatives available, and the relative likelihood and reversibility of complications with each approach.